Hemostemix Inc is seeing a notable rise in its stock price, making headlines in the TSXV market.
Hemostemix Inc (HEM.V) is up today, gaining 7.69% as investors respond positively to the company's recent activities and market positioning. With a market cap of about CA$12.3 million, this small-cap stock is attracting attention on the TSX Venture Exchange.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$12.30M
52W high
$0.14
52W low
$0.04
1W change
+8.33%
Beta
0.61
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1376.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1376.9% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
139.9%
Annualized
90-Day Vol
115.6%
Annualized
Trend (90d)
-31.1%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.10 |
| 60 trading days | C$0.06 | C$0.03 – C$0.12 |
| 90 trading days | C$0.06 | C$0.03 – C$0.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on Hemostemix Inc as it pursues private placements and strategic initiatives that could strengthen its market presence and operational capabilities.
Hemostemix Inc's stock price reaches CA$0.07
Today's increase in stock price shows a growing interest in Hemostemix's potential amid its ongoing financial activities.
Bull case
The recent rise in Hemostemix's stock price likely reflects increasing investor confidence following successful private placements. These placements enhance its financial resources and operational initiatives, which can be a positive sign for future growth.
Bear case
Despite today's gains, investors should stay cautious. Hemostemix operates in a volatile sector with limited coverage, making it vulnerable to fluctuations based on market sentiment and operational performance.
Recent Performance Overview
Advertisement
Hemostemix Inc has shown strong performance today, with its stock price climbing to CA$0.07. This increase is significant for a company of its size, indicating a possible shift in investor sentiment.
Understanding the Growth Drivers
The recent rise in Hemostemix's stock can be linked to its ongoing private placements aimed at strengthening its financial position. The company closed a notable private placement in June 2026, raising CA$360,000, which may have boosted investor confidence.
Navigating the Future
As Hemostemix continues its strategic financial maneuvers, investors should closely monitor the company's developments. While today's performance is promising, the inherent risks of small-cap investments remain.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
